Skip to main content
. 2022 Jun;14(6):2034–2044. doi: 10.21037/jtd-21-1924

Figure 4.

Figure 4

PFS by treatment in OSUM and E20ID. PFS, progression-free survival; OSUM, other single uncommon mutation; TKI, tyrosine kinase inhibitor; E20ID, exon 20 insertion/duplication.